Apr 13, 2024, 06:43
Agenus announced updated Phase 1 data and progress botensilimab/balstilimab combination in metastatic MSS colorectal cancer
Agenus shared on LinkedIn:
“Today we announced updated Phase 1 data and progress on our investigational botensilimab/balstilimab combination in patients with metastatic MSS colorectal cancer. Get the latest.”
Source: Agenus/LinkedIn
Apr 30, 2024, 15:44